Roche agrees to pay $21m to settle Enzo infringement suit
Swiss pharmaceutical company Roche Diagnostics has agreed to pay $21 million as part of a settlement to a patent infringement case with New York-based Enzo Biochem.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
23 April 2019 Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties.
23 April 2019 Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties.
23 April 2019 Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties.